- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05578157
MENDiP: Measurements of Overnight Penile Temperature to Evaluate Nocturnal Erection Detection in Patients With Absence of Erectile Functioning After Robot-assisted Radical Prostatectomy (MENDiP)
October 10, 2022 updated by: Hille Torenvlied, St. Antonius Hospital
Nocturnal erection detection with the outdated RigiScan is the golden standard for erectile dysfunction (ED) nature differentiation.
The Staying Hot and Feeling Hot study have shown that nocturnal erection detection is feasible with patient-friendly overnight penile temperature measurements.
The question has arisen whether the penile temperature methodology is also capable to detect the absence of nocturnal erections, which is essential for clinical implementation in erectile dysfunction diagnostics.
The objective of the MENDiP-study is to determine the feasibility to detect the absence of nocturnal erections with overnight penile temperature sensors.
Furthermore, the MENDiP study functions as a first pilot trial to investigate the effect of age on the penile temperature during nocturnal erections in test subjects with normal erectile functioning.
This is done in an observational study with a longitudinal design in which pre- and postoperative ambulatory overnight measurements are performed in patients, aged 55 - 70 years with preoperative normal sexual functioning, undergoing a non- or unilateral nerve-sparing robot assisted radical prostatectomy.
Study Overview
Status
Not yet recruiting
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
15
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Hille Torenvlied, MSc.
- Phone Number: +31883202500
- Email: h.torenvlied@antoniusziekenhuis.nl
Study Locations
-
-
Utrecht
-
Nieuwegein, Utrecht, Netherlands, 3435CM
- St. Antonius Ziekenhuis
-
Contact:
- Hille Torenvlied, MSc
- Phone Number: +31883202500
- Email: h.torenvlied@antoniusziekenhuis.nl
-
Sub-Investigator:
- Karlijn van Adrichem, BSc.
-
Principal Investigator:
- Jack Beck, dr., MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
53 years to 68 years (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
Male
Sampling Method
Non-Probability Sample
Study Population
Fifteen patients, aged 55 - 70 years, who will undergo a non- or unilateral-nerve-sparing robot assisted radical prostatectomy will be included in case preoperative normal erectile functioning and postoperative complete impotence at three months after surgery.
Description
Inclusion Criteria:
Preoperative measurement:
- Aged 55 - 70 years
- Prostatecancer patients undergoing a non-/unilateral-nerve-sparing radical prostatectomy (RARP)
- Pre-operative IIEF-5 score > 21
Postoperative measurement
- Inclusion criteria of pre-operative measurement
- Preoperative penile temperature increase during first nocturnal erection of minimally 0.4 degrees Celsius
- Post-operative IIEF-5 score < 12 with absence of morning erections
Exclusion Criteria:
- Test subjects who are unwilling to sign informed consent
- Test subjects with erectile dysfunction before RARP (IIEF-5 score of below 22)
- (History of) sickle cell aneamia, atherosclerosis and diabetes type I or II. These conditions might influence penile blood circulation and therefore the accuracy of the study outcomes.
- (History of) REM-sleep behavior disorder or other sleep disorders such as restless legs syndrome, insomnia, and sleep apnea
- Usage of sleeping pills or benzodiazepines.
- Postoperative results will be excluded from the study in case of presence of nocturnal erections according to the RigiScan data.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Group 1
Age 55 - 60 years
|
The Feeling Hot sensor is a proof-of-concept system, which can measure overnight penile, thigh and air temperature.
|
Group 2
Age 60 - 65 years
|
The Feeling Hot sensor is a proof-of-concept system, which can measure overnight penile, thigh and air temperature.
|
Group 3
Age 65 - 70 years
|
The Feeling Hot sensor is a proof-of-concept system, which can measure overnight penile, thigh and air temperature.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Detectability absence nocturnal erections
Time Frame: 9 hours
|
Visual detectability of the presence and absence of nocturnal erections in overnight penile temperature measurements
|
9 hours
|
Penile temperature REM-sleep
Time Frame: 9 hours
|
Maximal variation in penile temperature during REM-sleep in case of presence and absence of nocturnal erections
|
9 hours
|
Penile temperature nocturnal erection
Time Frame: 9 hours
|
Maximal variation in penile temperature during nocturnal erections in men aged 55 - 70 years
|
9 hours
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Demographic data
Time Frame: 1 year
|
age, BMI, surgeries, comorbidities (diabetes, hypertension, hyperlipidemia), medication, status of smoking and alcohol consumption
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jack Beck, dr., MD, Urologist
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
January 18, 2023
Primary Completion (Anticipated)
June 30, 2023
Study Completion (Anticipated)
October 10, 2023
Study Registration Dates
First Submitted
October 10, 2022
First Submitted That Met QC Criteria
October 10, 2022
First Posted (Actual)
October 13, 2022
Study Record Updates
Last Update Posted (Actual)
October 13, 2022
Last Update Submitted That Met QC Criteria
October 10, 2022
Last Verified
October 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ABR: 82813
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Erectile Dysfunction
-
Cairo UniversityRecruitingErectile Dysfunction | Erectile Dysfunction Following Radical Prostatectomy | Erectile Dysfunction Following Simple Prostatectomy | Erectile Dysfunction With Diabetes Mellitus | Erectile Dysfunction Due to Arterial Disease | Erectile Dysfunction Due to Injury | Erectile Dysfunction Due to Neuropathy and other conditionsEgypt
-
University of VirginiaActive, not recruitingErectile Dysfunction | Erectile Dysfunction Following Radical Prostatectomy | Erectile Dysfunction Following Radiation Therapy | Erectile Dysfunction Due to General Medical Condition | Erectile Dysfunction Due to Arterial InsufficiencyUnited States
-
University of BaghdadCompletedSexual Dysfunction | Erectile Dysfunction | Erectile Dysfunction Following Radical Prostatectomy | Erectile Dysfunction Following Radiation Therapy | Sexual Abstinence | Erectile Dysfunction With Diabetes Mellitus | Sexual Desire Disorder | Erectile Dysfunction Following Cryotherapy | Erectile Dysfunction... and other conditionsIraq
-
BayerCompletedSexual Dysfunction | Male Erectile DysfunctionBelgium, Italy, France, Germany, Spain, Netherlands, South Africa
-
Cairo UniversityCompletedVasculogenic Erectile DysfunctionEgypt
-
InitiaTerminatedVasculogenic Erectile DysfunctionIsrael
-
InitiaCompletedVasculogenic Erectile DysfunctionIsrael
-
InitiaCompletedVasculogenic Erectile DysfunctionCzech Republic, Lithuania, Netherlands, Palestinian Territories, Occupied
-
Rexahn Pharmaceuticals, Inc.CompletedErectile Dysfunction (ED)United States
-
SK Chemicals Co., Ltd.TerminatedMale Erectile Dysfunction
Clinical Trials on Feeling Hot sensor
-
St. Antonius HospitalCompletedErectile DysfunctionNetherlands
-
St. Antonius HospitalCompletedErectile DysfunctionNetherlands
-
Sprim Advanced Life SciencesArtsana S.p.a.CompletedFeeding Behavior
-
Karolinska InstitutetRegion Östergötland; Region Skane; Region StockholmRecruiting
-
Royal Free Hospital NHS Foundation TrustUniversity College, LondonUnknownDepressive Disorder | Covid19 | Anxiety Disorders | Post Traumatic Stress Disorder
-
University of California, IrvineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Fundacio Salut i Envelliment UABRecercaixa; Equip Atencio Primaria SardenyaCompletedAging | Self Care | Health Literacy | Social Capital | Subjective Health | Health Status Disparities
-
University of ArizonaCompletedInflammation | Aging | Depression, AnxietyUnited States
-
Seyma ErtugralCompletedBreast Pumping | Breast Milk Collection | Massage TherapyTurkey
-
Riphah International UniversityNot yet recruiting